← Back to Patent Explorer
US4117134A Expired / Lapsed US ⏱️ 0.0 years remaining

4,5-dihydro-4,5-dioxo-1h-1-benzopyrano (2,3-b)-pyridine-3-carboxylic acids, salts and esters

Assignee: Warner Lambert Co LLC
•
Filing: 1978-06-13
•
Granted: 1978-09-26
•
Expires: 1998-06-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention relates to compounds of the formula ##STR1## wherein R 1 is hydrogen, lower alkyl, halogen, hydroxy or lower alkoxy; R 2 is hydrogen or lower alkyl; R 3 is hydrogen or lower alkyl; and the pharmaceutically acceptable, non-toxic salts thereof. The compounds of the invention are active in the prevention of allergic and asthmatic reactions in mammals.

Inventors

  • 👤 David T. Connor
  • 👤 Maximilian VON Strandtmann

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 11:53
CPC Classifications
C; C07; C07D; C07D491/00; C07D491/02; C07D491/04; C07D311/00; C07D311/02; C07D311/04; C07D311/22

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 40 words
A compound of the formula VII: ##STR8## wherein R 1 is hydrogen, lower alkyl, halogen, hydroxy or lower alkoxy; R 2 is hydrogen or lower alkyl; R 3 is hydrogen or lower alkyl; and the pharmaceutically acceptable, non-toxic salts thereof.
Claim 2
Dependent Claim 40 words
A compound of the formula VII: ##STR8## wherein R 1 is hydrogen, lower alkyl, halogen, hydroxy or lower alkoxy; R 2 is hydrogen or lower alkyl; R 3 is hydrogen or lower alkyl; and the pharmaceutically acceptable, non-toxic salts thereof.
Claim 3
Dependent Claim 21 words
A compound according to claim 1 wherein R 1 , R 2 and R 3 are each hydrogen or lower alkyl.
Claim 4
Dependent Claim 23 words
A compound according to claim 1 wherein R 1 is hydrogen, and R 2 and R 3 are each hydrogen or lower alkyl.
Claim 5
Dependent Claim 10 words
A compound according to claim 1 which is ethyl 4,5-dihydro-4,5-dioxo-1H-1-benzopyrano[2,3-b]pyridine-3-carboxylate.
Claim 6
Dependent Claim 10 words
A compound according to claim 1 which is 4,5-dihydro-4,5-dioxo-1H-1-benzopyran[2,3-b]pyridine-3-carboxylic acid.
Claim 7
Dependent Claim 10 words
A compound according to claim 1 which is 1-methyl-4,5-dihydro-4,5-dioxo-1H-1-benzopyrano[2,3-b]pyridine-3-carboxylic acid.
Claim 8
Dependent Claim 60 words
A pharmaceutical composition for alleviating allergic manifestations in mammals comprising an effective amount of a compound of the formula VII. ##STR9## wherein R 1 is hydrogen, lower alkyl, hydroxy or lower alkoxy; R 2 is hydrogen or lower alkyl; R 3 is hydrogen or lower alkyl; and the pharmaceutically acceptable, non-toxic salts thereof, together with an inert pharmaceutical carrier therefor.
Claim 9
Dependent Claim 60 words
A pharmaceutical composition for alleviating allergic manifestations in mammals comprising an effective amount of a compound of the formula VII. ##STR9## wherein R 1 is hydrogen, lower alkyl, hydroxy or lower alkoxy; R 2 is hydrogen or lower alkyl; R 3 is hydrogen or lower alkyl; and the pharmaceutically acceptable, non-toxic salts thereof, together with an inert pharmaceutical carrier therefor.
Claim 10
Independent Claim 60 words
A method of preventing allergic manifestations in mammals in need thereof which comprises the administration of an effective amount of a compound of the formula VII: ##STR10## wherein R 1 is hydrogen, lower alkyl, halogen, hydroxy or lower alkoxy; R 2 is hydrogen or lower alkyl; R 3 is hydrogen or lower alkyl; and the pharmaceutically acceptable, non-toxic salts thereof.
Claim 11
Independent Claim 60 words
A method of preventing allergic manifestations in mammals in need thereof which comprises the administration of an effective amount of a compound of the formula VII: ##STR10## wherein R 1 is hydrogen, lower alkyl, halogen, hydroxy or lower alkoxy; R 2 is hydrogen or lower alkyl; R 3 is hydrogen or lower alkyl; and the pharmaceutically acceptable, non-toxic salts thereof.

References Cited (Backward Citations)

JPS4720627U Cited
DE2416519A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-09-25 1982-03-27 1982-09-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-09-25 1986-03-27 1986-09-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-09-25 1990-03-27 1990-09-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag